0001671077false--12-31Q22021falseNC0.0012500000000000.00110000000014350000100050000.03004415001500150022502250225000016710772021-01-012021-06-3000016710772021-02-012021-02-0500016710772018-06-012018-06-180001671077medspa:BenzionsConsultingAgreementMember2021-02-012021-02-1200016710772021-02-012021-02-040001671077medspa:SoleDirectorAndOfficerMember2021-06-300001671077medspa:SoleDirectorAndOfficerMember2021-01-012021-06-300001671077medspa:SoleDirectorAndOfficerMember2021-02-012021-02-040001671077medspa:SoleDirectorAndOfficerMember2020-06-3000016710772022-02-012022-02-110001671077medspa:PeterLCokerMember2021-08-012021-08-100001671077medspa:PeterLCokerMember2021-05-012021-05-100001671077medspa:PeterLCokerMember2021-05-1000016710772021-05-012021-05-1200016710772021-08-012021-08-1200016710772021-11-012021-11-1200016710772021-02-1200016710772021-02-012021-02-1200016710772021-05-120001671077medspa:PeterLCokerMember2022-05-012022-05-100001671077medspa:PeterLCokerMember2022-02-012022-02-100001671077medspa:PeterLCokerMember2021-11-012021-11-100001671077medspa:FeburaryFourTwoThousandTwentyOneMembermedspa:KynsonHealthLimitedMember2021-06-300001671077medspa:FeburaryFourTwoThousandTwentyOneMembermedspa:KynsonHealthLimitedMember2021-01-012021-06-300001671077us-gaap:RetainedEarningsMember2021-06-300001671077us-gaap:AdditionalPaidInCapitalMember2021-06-300001671077us-gaap:CommonStockMember2021-06-300001671077us-gaap:RetainedEarningsMember2021-04-012021-06-300001671077us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001671077us-gaap:CommonStockMember2021-04-012021-06-3000016710772021-03-310001671077us-gaap:RetainedEarningsMember2021-03-310001671077us-gaap:AdditionalPaidInCapitalMember2021-03-310001671077us-gaap:CommonStockMember2021-03-3100016710772021-01-012021-03-310001671077us-gaap:RetainedEarningsMember2021-01-012021-03-310001671077us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001671077us-gaap:CommonStockMember2021-01-012021-03-310001671077us-gaap:RetainedEarningsMember2020-12-310001671077us-gaap:AdditionalPaidInCapitalMember2020-12-310001671077us-gaap:CommonStockMember2020-12-3100016710772020-06-300001671077us-gaap:RetainedEarningsMember2020-06-300001671077us-gaap:AdditionalPaidInCapitalMember2020-06-300001671077us-gaap:CommonStockMember2020-06-300001671077us-gaap:RetainedEarningsMember2020-04-012020-06-300001671077us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001671077us-gaap:CommonStockMember2020-04-012020-06-3000016710772020-03-310001671077us-gaap:RetainedEarningsMember2020-03-310001671077us-gaap:AdditionalPaidInCapitalMember2020-03-310001671077us-gaap:CommonStockMember2020-03-3100016710772020-01-012020-03-310001671077us-gaap:RetainedEarningsMember2020-01-012020-03-310001671077us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001671077us-gaap:CommonStockMember2020-01-012020-03-3100016710772019-12-310001671077us-gaap:RetainedEarningsMember2019-12-310001671077us-gaap:AdditionalPaidInCapitalMember2019-12-310001671077us-gaap:CommonStockMember2019-12-3100016710772020-01-012020-06-3000016710772020-04-012020-06-3000016710772021-04-012021-06-3000016710772020-12-3100016710772021-06-3000016710772021-07-30iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the fiscal year ended: June 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from ___________ to ___________

Commission file number: 333-210922

MED SPA VACATIONS INC.

(Exact name of registrant as specified in its charter)

Nevada

47-5268172

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

500 W. 5th Street, Suite 800, PMB #59, Winston Salem, NC 27101

(Address of principal executive offices)

(845) 548-3280

(Registrant s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

(Note: The registrant is a voluntary filer of reports under Section 13 or 15(d) of the Securities Exchange Act of 1934; the registrant has filed during the preceding 12 months all reports it would have been required to file by Section 13 or 15(d) of the Securities Exchange Act of 1934 if the registrant had been subject to one of such Sections.)

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if this registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of July 30, 2021, there were 10,005,000 shares of the registrant’s common stock, par value $0.001 per share, issued and outstanding.

MED SPA VACATIONS INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021

TABLE OF CONTENTS

		PAGE

	PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)	F-1

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	3

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	7

Item 4.	Controls and Procedures	7

	PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	8

Item 1A.	Risk Factors	8

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	8

Item 3.	Defaults Upon Senior Securities	8

Item 4.	Mine Safety Disclosures	8

Item 5.	Other Information	8

Item 6.	Exhibits	9

	SIGNATURES	10

Table of Contents

MED SPA VACATIONS, INC.

INDEX TO AUDITED FINANCIAL STATEMENTS

FOR THE PERIOD ENDED JUNE 30, 2021

	Page

Unaudited Balance Sheets		F-2

Unaudited Statements of Operations		F-3

Unaudited Statements of Stockholders’ Deficit		F-4

Unaudited Statements of Cash Flows		F-5

Notes to the Unaudited Financial Statements		F-6

F-1

Table of Contents

MED SPA VACATIONS INC.

Balance Sheets

(Unaudited)

	June 30,			December 31,
	2021			2020
ASSETS
Current Assets:
Cash	$	26,220		$	-
Total Current Assets		26,220			-

Total Assets	$	26,220		$	-

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities:
Accounts payable and accrued liabilities	$	2,845		$	36,664
Due to related party		-			44,322
Note payable		100,000			-
Total Current Liabilities		102,845			80,986

Total Liabilities		102,845			80,986

Stockholders' Deficit:
Preferred stock, $0.001 par value, 25,000,000 shares authorized, no shares issued and outstanding		-			-
Common stock, $0.001 par value, 100,000,000 shares authorized, 10,005,000 shares and 14,350,000 shares issued and outstanding at June 30,2021 and December 31, 2020, respectively		10,005			14,350
Additional paid-in capital		395,296			272,445
Accumulated deficit		(481,926	)		(367,781	)
Total Stockholders' Deficit		(76,625	)		(80,986	)
Total Liabilities and Stockholders' Deficit	$	26,220		$	-

The accompanying notes to the unaudited financial statements are an integral part of these statements.

F-2

Table of Contents

MED SPA VACATIONS INC.

Statements of Operations

(Unaudited)

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2021			2020		2021			2020

Operating Expenses
General and administrative	$	2,871		$	-	$	4,441		$	-
Professional fees		31,081			-		106,616			-
Total Operating Expenses		33,952			-		111,057			-

Loss from operations		(33,952	)		-		(111,057	)		-

Other Income (Expense)
Interest expense		(1,929	)		-		(3,088	)		-
Net Other Expense		(1,929	)		-		(3,088	)		-

Loss Before Provision for Income Taxes		(35,881	)		-		(114,145	)		-

Provision for Income Taxes		-			-		-			-
Net Loss	$	(35,881	)	$	-	$	(114,145	)	$	-

Net loss per common share: Basic and Diluted	$	(0.00	)	$	-	$	(0.01	)	$	-

Weighted average number of common shares outstanding: Basic and Diluted		10,005,000			14,350,000		10,869,199			14,350,000

The accompanying notes to the unaudited financial statements are an integral part of these statements.

F-3

Table of Contents

MED SPA VACATIONS INC.

Statements of Stockholders’ Deficit

(Unaudited)

For the Six Months Ended June 30, 2021

							Additional
	Common stock						Paid-in		Accumulated
	Shares			Amount			Capital		Deficit			Total
Balance - December 31 2020		14,350,000		$	14,350		$	272,445	$	(367,781	)	$	(80,986	)
Cancellation of common stock		(4,345,000	)		(4,345	)		4,345		-			-
Debt forgiveness by related party		-			-			118,506		-			118,506
Net loss		-			-			-		(78,264	)		(78,264	)
Balance - March 31 2021		10,005,000			10,005			395,296		(446,045	)		(40,744	)
Net loss		-			-			-		(35,881	)		(35,881	)
Balance - June 30 2021		10,005,000		$	10,005		$	395,296	$	(481,926	)	$	(76,625	)

For the Six Months Ended June 30, 2020

					Additional
	Common stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance - December 31 2019		14,350,000	$	14,350	$	272,445	$	(321,123	)	$	(34,328	)
Net loss		-		-		-		-			-
Balance - March 31 2020		14,350,000		14,350		272,445		(321,123	)		(34,328	)
Net loss		-		-		-		-			-
Balance - June 30 2020		14,350,000	$	14,350	$	272,445	$	(321,123	)	$	(34,328	)

The accompanying notes to the unaudited financial statements are an integral part of these statements.

F-4

Table of Contents

MED SPA VACATIONS INC.

Statements of Cash Flow

(Unaudited)

	Six Months Ended
	June 30,
	2021			2020

Cash Flows from Operating Activities
Net loss	$	(114,145	)	$	-
Changes in operating assets and liabilities:
Expenses paid by related party		74,184			875
Accounts payable and accrued liabilities		(36,907	)		(9,717	)
Accrued note payable interest		3,088			-
Net cash used in operating activities		(73,780	)		(8,842	)

Cash Flows from Financing Activities
Repayment of promissory note payable		(150,000	)		-
Proceed of promissory note payable		150,000			-
Proceed of promissory note payable - related party		100,000			-
Net cash provided by Financing Activities		100,000			-

Net change in cash for period		26,220			(8,842	)
Cash at beginning of period		-			8,842
Cash at end of period	$	26,220		$	-

Supplemental Cash Flow Information
Cash paid for income taxes	$	-		$	-
Cash paid for interest	$	2,250		$	-

Non Cash Investing and Financing Activities
Related party debt forgiven recorded as additional paid in capital	$	118,506		$	-
Cancellation of common stock	$	4,345		$	-

The accompanying notes to the unaudited financial statements are an integral part of these statements.

F-5

Table of Contents

MED SPA VACATIONS INC.

Notes to the Unaudited Financial Statements

June 30, 2021

Note 1 - Organization, Description of Business

Med Spa Vacations, Inc, (the “Company”), was incorporated in the State of Nevada on October 5, 2015. The Company’s office address is 500 W. 5th Street, Suite 800, Winston Salem, NC 27101.

The Company’s original plan was to develop a business that specialized in marketing health and wellness vacations to both individuals and corporate groups looking to revitalize and develop a fuller day-to-day life. The Company was not successful in its efforts and discontinued that line of business. Since that time, the Company has been a shell company, as that term is defined in Rule 12b-2 of the Exchange Act of 1934, as amended (the “Exchange Act”)

Going forward, the Company intends to seek, investigate and, if such investigation warrants, engage in a business combination with a private entity whose business presents an opportunity for the Company’s shareholders. No specific assets or businesses have been definitively identified and there is no certainty that any such assets or business will be identified or that any transactions will be consummated.

Change of Control

On February 4, 2021, Kynson Health Limited, a BVI entity (Kynson”), which was our majority stockholder, closed stock purchase and sale transactions pursuant to which Kynson sold an aggregate of 9,985,329 restricted shares of the Company’s Common Stock to eleven purchasers at a purchase price of $0.030044 per share, or an aggregate purchase price of $299,998.60 (the “Kynson Share Sale Transaction”). Upon the closing of the Kynson Share Sale Transaction, OuYang XingYing, who controlled Kynson, and was our President, Secretary and Treasurer and sole member of the Company’s board of the directors, resigned from all positions she held with the Company and, in connection with her resignation, she relinquished her roles as the Company’s “Principal Executive Officer” and “Principal Financial and Accounting Officer.” Effective immediately upon Ms. Yang’s resignation, John D. Rollo was appointed as the Company’s President, Secretary and Treasurer, and as the sole member of the Company’s board of the directors. In connection with his appointments, Mr. Rollo was designated as the “Principal Executive Officer” and “Principal Financial and Accounting Officer” of the Company for SEC reporting purposes. In connection with and as a condition to, the consummation of the Kynson Share Sale Transaction, eleven shareholders of the Company returned an aggregate of 4,345,000 shares of the Company’s Common Stock to the Company for cancellation, in consideration for $0.001 per share. As a result of the Kynson Share Sale Transaction and simultaneous cancellation of 4,345,000 shares by eleven stockholders, there was a change in control of the Company.

On May 21, 2021, John D. Rollo, the President, Treasurer and Secretary and the sole member of the Company’s board of directors (the “Board”), resigned from all positions he held with the Company. Effective immediately upon Mr. Rollo’s resignation, Irwin Schneidmill was appointed as the Company’s President, Secretary and Treasurer, and as the sole member of the Company’s board of the directors. In connection with his appointments, Mr. Schneidmill was designated as the “Principal Executive Officer” and “Principal Financial and Accounting Officer” of the Company for SEC reporting purposes.

Note 2 - Summary of Significant Accounting Policies

Basis of Presentation of Unaudited Interim Financial Statements

The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2021, and the results of operations and cash flows for the periods presented. The results of operations for the period ended June 30, 2021, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited interim financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 30, 2021.

F-6

Table of Contents

Use of Estimates and Assumptions

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. The Company had $26,220 and $0 in cash as of June 30, 2021, and December 31, 2020, respectively.

Note 2 – Going Concern

Going concern and Liquidity Considerations

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of June 30, 2021, the Company has reoccurring losses from operations, an accumulated deficit of $481,926 and has earned no revenues. The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending December 31, 2021.

The ability of the Company to emerge from the early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.

These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 3 – Note Payable

Note payable

On February 12, 2021, the Company received a loan in the amount of $150,000 (the “Loan”) from Hometown International Inc., a Nevada corporation (“Hometown”). To evidence the Loan, the Company issued a promissory note in the principal amount of $150,000 (the “Note”) to Hometown, with a maturity date of February 11, 2022. Interest accrues on the principal amount of the Note at the rate of six percent (6%) per annum, and shall be paid on a quarterly basis, in the amount of $2,250 per quarter, on the following dates: May 12, 2021, August 12, 2021, November 12, 2021, and February 11, 2022. The Company may prepay any amounts due under the Note without penalty or premium. On May 12, 2021, the Company repaid in full all outstanding principal note of $150,000 and an interest of $2,250. The Company did not incur any early termination penalties as a result of the repayment of indebtedness and termination of the loan.

Note payable – related party

On May 10, 2021, The Company received a loan of $100,000 from Peter L. Coker, Sr., a shareholder of the Company. To evidence said loan, the Company issued to Mr. Coker a promissory note in the principal amount of $100,000 (the “Note”), with a maturity date of May 9, 2022. Interest on the Note accrues on the principal amount at the rate of six percent (6%) per annum, and shall be paid on a quarterly basis, in the amount of $1,500 per quarter, on the following dates: August 10, 2021, November 10, 2021, February 10, 2022, and May 10, 2022. The Company may prepay any amounts due under the Note without penalty or premium.

F-7

Table of Contents

During the six months ended June 30, 2021, the Company recorded interest expense of $3,088 and repaid $2,250 interest. As of June 30, 2021, the outstanding balance of promissory note – related party and accrued interest were $100,000 and $838, respectively.

Note 4 – Related Party Transactions

	(i)	During the six months ended June 30, 2021, and 2020, the Company’s controlling shareholder advanced to the Company an amount of $78,184 and $875, respectively, to pay certain expenses on behalf of the Company.

		On February 4, 2021, the former majority shareholder of the Company, which was controlled by the Company’s former sole officer and director, canceled and released the Company from $118,506 it was owed.

	(ii)	During the six months ended June 30, 2021, the Company paid $3,000 management fee to the Company’s sole Director and Officers.

Note 5 - Stockholders' Equity

On February 4, 2021, eleven shareholders of the Company returned an aggregate of 4,345,000 shares (the “Cancelled Shares”) of the Company’s Common Stock to the Company for cancellation. The Cancelled Shares were returned to the Company’s number of authorized and unissued shares of Common Stock.

As of June 30, 2021, and December 31, 2020, the Company had 10,005,000 and 14,350,000 shares of Common Stock issued and outstanding, respectively.

Note 6 – Commitments

On February 5, 2021, the Company entered into a one-year consulting agreement (the “Tryon Consulting Agreement”) with Tryon Capital LLC, a North Carolina limited liability company (“Tryon”), pursuant to which Tryon will provide the Company with financial and strategic consulting services in consideration for a consulting fee of $2,500 per month. The Tryon Consulting Agreement was terminated on June 18, 2021 with effective date of June 30, 2021. The Company and Tryon also agreed to release each other from any claims relating to the Tryon Consulting Agreement.

On February 12, 2021, the Company entered into a one-year consulting agreement (the “Benzions Consulting Agreement”) with Benzions LLC, a Delaware limited liability company (“Benzions”), effective as of March 1, 2021, pursuant to which Benzions will provide certain strategic advisory and investor relations services to the Company in consideration for a consulting fee of $4,000 per month. The Benzions Consulting Agreement was terminated on May 19, 2021 with effective date of immediately. The Company and Benzions also agreed that all responsibilities of the other party under the Benzions Consulting Agreement have been fully performed.

On June 18, 2018, the Company entered into a consulting agreement (the “Benchmark Consulting Agreement”) with Benchmark Capital, LLC, a New Jersey limited liability company (“Benchmark”), effective as of July 1, 2021, pursuant to which Benchmark will assist the Company in connection with all filling required by the Company to be made with the SEC, for a consulting fee of $2,500 per month. The Benchmark Consulting Agreement can be terminated by either party, at any time, upon 30 days’ written notice.

F-8

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

Except for historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses. Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes” and similar language. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed herein. You should carefully review the risks described herein and in other documents we file from time to time with the Securities and Exchange Commission. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances after the date of this document.

Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements.

All references in this Form 10-Q to the “Company,” “we,” “us,” or “our,” are to Med Spa Vacations Inc.

General Overview

We were incorporated in the State of Nevada on October 5, 2015 to develop a business that specializes in marketing health and wellness vacations to both individuals and corporate groups looking to revitalize and develop a fuller day-to-day life. Our office address is 500 W. 5th Street, Suite 800, PMB #59, Winston Salem, NC 27101.

Because we were not able to raise sufficient capital to execute our original business plan, we discontinued that line of business.

The Company is a shell company, as that term is defined in Rule 12b-2 of the Exchange Act of 1934, as amended. The Company is seeking a business combination with a private entity whose business would present an opportunity for its shareholders. No specific assets or businesses have been definitively identified and there is no certainty that any such assets or business will be identified or that any transactions will be consummated.

On February 4, 2021, our controlling stockholder Kynson Health Limited, a company incorporated and existing under the law of the British Virgin Islands, closed stock purchase and sale transactions pursuant to which Kynson Health sold an aggregate of 9,985,329 restricted shares (the “Shares”) of the Company’s common stock, $0.001 par value per share, to eleven purchasers at a purchase price of $0.030044 per share, or an aggregate purchase price of $299,998.60 (the “Share Sale Transaction”). The shares represented approximately 99.8% of the Company’s issued and outstanding shares of common stock as of the date of the closing of the Share Sale Transaction, taking into account the share cancellations further described below.

On February 4, 2021, in connection with, and as a condition to, the consummation of the Share Sale Transaction, eleven shareholders of the Company returned an aggregate of 4,345,000 shares of the Company’s common stock to the Company for cancellation, in consideration for $0.001 per share. Said shares were returned to the Company’s number of authorized and unissued shares of common stock.

We have no revenues and limited cash on hand. We have sustained losses since inception. We have never declared bankruptcy, been in receivership, or involved in any kind of legal proceeding.

Table of Contents

Recent Developments

As part of the restructuring of the Company’s management, the Company and Benzions, LLC, a Delaware limited liability company (“Benzions”), executed a Termination of Consulting Agreement on May 19, 2021, pursuant to which the parties agreed to terminate the Consulting Agreement, dated March 1, 2021, between the parties. The termination was effective immediately.

On May 10, 2021, the Company received a loan of $100,000 from Peter L. Coker, Sr., a shareholder of the Company. To evidence said loan, the Company issued to Mr. Coker a promissory note in the principal amount of $100,000 (the “Coker Note”), with a maturity date of May 9, 2022. Interest on the Coker Note accrues on the principal amount at the rate of six percent (6%) per annum, and shall be paid on a quarterly basis, in the amount of $1,500 per quarter, on the following dates: August 10, 2021, November 10, 2021, February 10, 2022, and May 10, 2022. The Company may prepay any amounts due under the Coker Note without penalty or premium. The proceeds were used by the Company to repay the note that was issued to Hometown International, Inc. (“Hometown”).

On May 12, 2021, the Company repaid in full all outstanding indebtedness owed pursuant to the promissory note, dated February 12, 2021, between the Company and Hometown (the “Hometown Note”). Although the Hometown Note was not due and payable until February 2022, the Company paid Hometown $150,000, plus interest in the amount of $2,250. The Company did not incur any early termination penalties as a result of the repayment of indebtedness and termination of the loan.

On May 21, 2021, John D. Rollo, the President, Treasurer and Secretary and the sole member of the Company’s board of directors (the “Board”), resigned from all positions he held with the Company. Effective immediately upon Mr. Rollo’s resignation, Irwin Schneidmill was appointed as the Company’s President, Secretary and Treasurer, and as the sole member of the Company’s board of the directors. There is no employment contract between the Company and Mr. Schneidmill and in consideration for his services, the Company is paying Mr. Schneidmill $1,000 per month.

On June 18, 2021, the Company, and Tyron Capital, LLC, a North Carolina limited liability company (“Tyron”), executed a Termination of Consulting Agreement, pursuant to which the parties agreed to terminate the Consulting Agreement, dated February 5, 2021, between the parties, such termination to be effective as of the close of business on June 30, 2021.

On June 18, 2021, the Company and Tyron also executed a Termination of Lease Agreement, pursuant to which the parties agreed to terminate the Lease Agreement, dated February 4, 2021, between the parties, such termination to be effective as of the close of business on June 30, 2021.

Results of Operations

Three Months Ended June 30, 2021, Compared to Three Months Ended June 30, 2020

Our results of operations for the three months ended June 30, 2021, and 2020 are summarized below:

	Three Months Ended
	June 30,
	2021		2020		Change
Revenue	$	-	$	-	$	-
Operating expenses		33,952		-		33,952
Other expenses		1,929		-		1,929
Net loss	$	35,881	$	-	$	35,881

Revenues

During the three months ended June 30, 2021, and 2020, we did not realize any revenues from operations.

Table of Contents

Operating Expenses

Operating expenses consisted entirely of professional fees of $31,081 and $2,871 general and administrative expenses during the three months ended June 30, 2021, compared to $0 during the three months ended June 30, 2020. This increase is primarily the result legal and consulting fees of $24,500 and other miscellaneous professional fees of $6,581 for maintaining reporting status with the Securities and Exchange Commission (“SEC”).

Other Expenses

Other expenses consisted of $1,929 interest of promissory notes payable.

Net Loss

As a result of the foregoing, we incurred a net loss of $35,881 for the three months ended June 30, 2021, compared to a net loss of $0 for the corresponding the three months ended June 30, 2020.

Six Months Ended June 30, 2021, Compared to Six Months Ended June 30, 2020

Our results of operations for the six months ended June 30, 2021, and 2020 are summarized below:

	Six Months Ended
	June 30,
	2021		2020		Change
Revenue	$	-	$	-	$	-
Operating expenses	$	111,057	$	-		111,057
Other expenses		3,088		-		3,088
Net loss	$	114,145	$	-	$	114,145

Revenues

During the six months ended June 30, 2021, and 2020, we did not realize any revenues from operations.

Operating Expenses

Operating expenses consisted entirely of professional fees of $106,616 and $4,441 general and administrative expenses during the six months ended June 30, 2021, compared to $0 during the six months ended June 30, 2020. This increase is primarily the result legal and consulting fees of $85,000 and other miscellaneous professional fees of $21,616 for maintaining reporting status with the Securities and Exchange Commission (“SEC”).

Other Expenses

Other expenses consisted of $3,088 interest of promissory notes payable.

Net Loss

As a result of the foregoing, we incurred a net loss of $114,145, for the six months ended June 30, 2021, compared to a net loss of $0 for the corresponding the six months ended June 30, 2020.

Liquidity and Capital Resources

	June 30,			December 31,
	2021			2020			Change
Cash	$	26,220		$	-		$	26,220
Total Assets	$	26,220		$	-		$	26,220
Total Liabilities	$	102,845		$	80,986		$	21,859
Stockholders' Deficit	$	(76,625	)	$	(80,986	)	$	4,361
Working Capital Deficiency	$	(76,625	)	$	(80,986	)	$	4,361

Table of Contents

As of the date of this report, we had yet to generate any revenues from our business operations.

As of June 30, 2021, we had current assets of $26,220, we had liabilities of $102,845, and our working capital deficit was $76,625. We anticipate that our current liquidity is not sufficient to meet the obligations associated with being a company that is fully reporting with the SEC.

To date, we have managed to keep our monthly cash flow requirement low for two reasons. First, our sole officer draws only a nominal salary at this time. Second, we have been able to keep our operating expenses to a minimum by operating in space provided at no expense by one of our shareholders.

We currently have no external sources of liquidity such as arrangements with credit institutions or off-balance sheet arrangements that will have or are reasonably likely to have a current or future effect on our financial condition or immediate access to capital.

Our financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplates our continuation as a going concern. We have not yet generated any revenue and have incurred losses to date of $481,926. In addition, our current liabilities exceed our current assets by $76,625. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations.

Cash Flows

	Six Months Ended
	June 30,
	2021			2020
Cash used in operating activities	$	(73,780	)	$	(8,842	)
Cash provided by Investing Activities	$	-		$	-
Cash provided by financing activities	$	100,000		$	-
Net Change In Cash	$	26,220		$	(8,842	)

Operating Activities

For the six months ended June 30, 2021, net cash used in operating activities was $73,780, related to our net loss of $114,145, reduced by an increase in expenses paid by related party of $74,184 and increased by a decrease in accounts payable and accrued liabilities of $33,819.

For the six months ended June 30, 2020, net cash used in operating activities was $8,842, related to our net loss of $0, reduced by an increase in expenses paid by related party of $875 and increased by a decrease in accounts payable and accrued liabilities of $9,717.

During the six months ended June 30, 2021, and 2020, the Company’s sole Director and Officer paid $74,184 and $875, respectively, on behalf of the Company for business operation purpose.

Investing Activities

The Company did not use any funds for investing activities during the six months ended June 30, 2021, and 2020.

Table of Contents

Financing Activities

The Company provided $100,000 and $0 by financing activities during the six months ended June 30, 2021, and 2020, respectively. During the six months ended June 30, 2021, the Company received a loan in the amount of $150,000, a loan from related party in the amount of $100,000 and repaid in full all outstanding principal loan of $150,000 and an interest of $2,250.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to select appropriate accounting policies and to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

Contractual Obligations

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed in our Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, as appropriate, to allow timely decisions regarding required disclosure.

Our management has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, management has concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting identified in connection with the evaluation we conducted on the effectiveness of our internal control over financial reporting as of June 30, 2021, that occurred during our first fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We know of no active or pending legal proceedings against us, nor are we involved as a plaintiff in any proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest adverse to us.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Other than as previously reported in our Current Reports on Form 8-K, we did not sell any unregistered securities during the three-month period ended June 30, 2021, or subsequent period through the date hereof.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

Table of Contents

ITEM 6. EXHIBITS

The following exhibits are included as part of this report:

Exhibit No.		Description

4.1		Promissory Note, dated May 10, 2021, issued by Med Spa Vacations Inc. to Peter L. Coker, Sr, in the principal amount of $100,000, filed by the Company on current report on Form 8-K dated May 10, 2021 and incorporated herein by reference

10.1		Termination of Consulting Agreement, dated May 19, 2021, by and between Med Spa Vacations Inc. and Benzions LLC. (filed by the Company on current report on Form 8-K dated May 10, 2021 and incorporated herein by reference)

10.2		Termination of Consulting Agreement, effective as of June 30, 2021, by and between the Company and Tryon Capital, LLC (filed by the Company on current report on Form 8-K dated June 30, 2021 and incorporated herein by reference)

10.3		Termination of Lease Agreement, effective as of June 30, 2021, by and between the Compnay and Tyron Capital, LLC (filed by the Company on current report on Form 8-K dated June 30, 2021 and incorporated herein by reference)

31.1 / 31.2 *		Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive and Financial and Accounting Officer

32.1 / 32.2 *		Rule 1350 Certification of Chief Executive and Financial and Accounting Officer

101.INS *		XBRL Instance Document

101.SCH *		XBRL Schema Document

101.CAL *		XBRL Calculation Linkbase Document

101.DEF *		XBRL Definition Linkbase Document

101.LAB *		XBRL Label Linkbase Document

101.PRE *		XBRL Presentation Linkbase Document

_______

*filed herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	MED SPA VACATIONS INC.

Dated: July 30, 2021	By:	/s/ Irwin Schneidmill
	Name:	Irwin Schneidmill
	Title:	President, Treasurer and Secretary (Principal Executive Officer and Principal Financial and Accounting Officer)

MED SPA VACATIONS INC. 10-Q